Status:
UNKNOWN
Analysis of the Microbiota and STEMI
Lead Sponsor:
University of Campania Luigi Vanvitelli
Conditions:
STEMI
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Brief Summary
Hyperglycemia is a common finding in patients diagnosed with acute coronary syndrome (ACS), and an independent predictor of mortality in patients with and without diabetes. Though percutaneous coronar...
Detailed Description
Hyperglycemia is a common finding in patients diagnosed with acute coronary syndrome (ACS) and is an independent predictor of mortality in patients with and without diabetes (1-4). Though percutaneous...
Eligibility Criteria
Inclusion
- aged \> 18 years
- STEMI acute admission event
Exclusion
- left ventricular ejection fraction \<25%,
- previous acute myocardial infarction
- previous percutaneous coronary intervention
- previous coronary artery by-pass
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03439592
Start Date
January 1 2016
End Date
June 1 2021
Last Update
October 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Raffaele Marfella
Naples, Italy, 80138